Stewart Appelrouth, Director at AIM ImmunoTech Inc. (AIM), bought 80,646 shares at $0.31 ($25K) on 2023-01-03, disclosed to the SEC on 2023-01-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| AIM | BUY | 2024-03-18 | $30K | — | Filing → |
| AIM | BUY | 2021-02-25 | $25K | — | Filing → |
| HEB | BUY | 2019-06-25 | $39K | — | Filing → |